5-Fluorouracil Ameliorates the Hematotoxicity Induced by Cyclophosphamide in Male Albino Rats

Table 1.

WBCs, RBCs, and platelets count, Hb,and Hct of rat treated with cyclophosphamideand/or 5-fluorouracil.

Groups

Parameters

Control

CPA

5-FU

CPA – 5-FU

Mean±E

Mean±E

Mean±E

Mean±E

WBCs count (x103/µ)

13.64±.65 bcd

5.10±.50 acd

10.0±.54 abd

3.36±.63 abc

RBCs count (x106/µ)

7.57±.22 bcd

4.78±.16 acd

5.72±.38 ab

5.52±.47 ab

Hemoglobin concentration (g/dl)

14.42±.66 bcd

8.94±.40 acd

12.04±.63 abd

11.54±.53 abc

Hematocrit (%)

44.12±.15 bcd

24.96±.86 acd

34.38±.77 ab

33.66±.85 ab

Platelets count (103/μl)

910.8±4.7 bc

149.2±9.1 acd

637.6±5.7 abd

876.4±1.6 bc

Significance at P < 0.05. CPA: cyclophosphamide; 5-FU: Fluorouracil, a Comparison of control and other groups; b Comparison of CPA and other groups; c Comparison of 5-FU and other groups; d Comparison of CPA - 5-FU and other groups.

Significance at P < 0.05. CPA: cyclophosphamide; 5-FU: Fluorouracil, a Comparison of control and other groups; b Comparison of CPA and other groups; c Comparison of 5-FU and other groups; d Comparison of CPA - 5-FU and other groups.